AI applied to drug research

Drug research has so far required lengthy and costly processes to analyze and assess molecular properties. But now, cutting-edge machine-learning systems make it possible to rapidly evaluate a full range of critical properties for potential drug candidates. Gianvito Grasso, CEO, and Stefano Muscat, co-founder of InVirtuoLabs—the Ticino-based startup that won the 2024 edition of the Boldbrain Startup Challenge—tell us more.

The full article in Italian is available by clicking the following link: